Medvedev A E, Sundan A, Espevik T
Institute of Cancer Research, University Medical Center, University of Trondheim, Norway.
Eur J Immunol. 1994 Nov;24(11):2842-9. doi: 10.1002/eji.1830241139.
Using agonistic antibodies (Ab) we have examined whether the 75-kDa chain of the tumor necrosis factor receptor (p75 TNFR) is capable of mediating cytotoxic response and gene regulation alone or in cooperation with p55 TNFR. Addition of an anti-p75 TNFR polyclonal antiserum or anti-p75 monoclonal antibody (mAb) plus anti-immunoglobulin (Ig) led to cytotoxic response of human KYM-1 rhabdomyosarcoma cells. Anti-p75 mAb alone had no effect pointing out the importance of strong receptor stimulation for signal transduction into the cell. Simultaneous triggering of both the p55 and p75 TNFR by agonistic Ab resulted in additive cytotoxic action on KYM-1 cells. The anti-p75 mAb 3H5, directed to a non-TNF binding site on the human p75 TNFR, was used to confirm further the ability of the p75 TNFR to potentiate p55 TNFR-mediated cell death. While exhibiting no cytotoxicity by its own, 3H5 significantly augmented the cytotoxic effect of the anti-p55 mAb htr9 towards KYM-1 cells. Neither the anti-p75 TNFR antiserum nor anti-p75 mAb were cytotoxic for human U937 cells suggesting that the cytolysis resulting from p75 TNFR cross-linking is cell specific. Noteworthy, stimulation of the p75 TNFR with mAb plus anti-Ig or polyclonal antiserum led to a marked enhancement of the p55 TNFR-induced U937 cell death, indicating collaboration between the two TNFR in induction of cytotoxicity also in this cell line. However, 3H5 mAb did not affect the ability of anti-p55 mAb to lyse U937 cells. Altogether, these data demonstrate the difference between KYM-1 and U937 cell lines with respect to the role for the p75 TNFR in mediating cytotoxicity. Both TNFR were found to mediate cytomegalovirus (CMV) promoter activation in human SW480T-beta Gal cells and nuclear transcription factor kappa B (NF-kappa B) induction in this cell line as well as in KYM-1 cells. It was demonstrated for the first time that independent stimulation of both TNFR resulted in an additive effect on the CMV promoter activation and induction of the NF-kappa B. Taken together, these results indicate that the p75 TNFR induces cytotoxicity in a cell-specific manner and potentiates p55 TNFR-mediated cytotoxic response and gene regulation.
我们使用激动性抗体(Ab)来研究肿瘤坏死因子受体的75-kDa链(p75 TNFR)是否能够单独介导细胞毒性反应和基因调控,或者与p55 TNFR协同作用。添加抗p75 TNFR多克隆抗血清或抗p75单克隆抗体(mAb)加抗免疫球蛋白(Ig)可导致人KYM-1横纹肌肉瘤细胞产生细胞毒性反应。单独使用抗p75 mAb没有效果,这表明强烈的受体刺激对于信号转导进入细胞很重要。激动性Ab同时触发p55和p75 TNFR会对KYM-1细胞产生累加的细胞毒性作用。针对人p75 TNFR上一个非TNF结合位点的抗p75 mAb 3H5,被用于进一步确认p75 TNFR增强p55 TNFR介导的细胞死亡的能力。虽然3H5自身不表现出细胞毒性,但它显著增强了抗p55 mAb htr9对KYM-1细胞的细胞毒性作用。抗p75 TNFR抗血清和抗p75 mAb对人U937细胞均无细胞毒性,这表明p75 TNFR交联导致的细胞溶解具有细胞特异性。值得注意的是,用mAb加抗Ig或多克隆抗血清刺激p75 TNFR会导致p55 TNFR诱导的U937细胞死亡显著增强,这表明在该细胞系中,两种TNFR在诱导细胞毒性方面也存在协同作用。然而,3H5 mAb并不影响抗p55 mAb裂解U937细胞的能力。总之,这些数据证明了KYM-1和U937细胞系在p75 TNFR介导细胞毒性作用方面的差异。在人SW480T-β半乳糖苷酶细胞中,发现两种TNFR均介导巨细胞病毒(CMV)启动子激活以及该细胞系和KYM-1细胞中核转录因子κB(NF-κB)的诱导。首次证明,独立刺激两种TNFR会对CMV启动子激活和NF-κB诱导产生累加效应。综上所述,这些结果表明p75 TNFR以细胞特异性方式诱导细胞毒性,并增强p55 TNFR介导的细胞毒性反应和基因调控。